XENE

NASDAQStock

Xenon Pharmaceuticals Inc.

$58.15-0.90 (-1.52%)

52-Week Range

$28.23

$62.76

Key Stats

Market Cap

4.5B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Volume

2.2M

Avg Volume

2.3M

Performance

+38.49%

+34.00%

+64.05%

YTD

+32.70%

+66.40%

+72.48%

+191.70%

Price Chart

ETF Exposure

XENE is held by 54 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	4	$233	$9.0M	0.30%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	21	$1K	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	36	$2K	$81.7M	0.11%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	6	$387	$61.4M	0.09%

PreviousPage 2 of 2

About XENE ETF Exposure

Xenon Pharmaceuticals Inc. (XENE) is held by 54 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 4.5B, XENE is a widely held institutional stock. The stock currently trades at $58.15. Investors can gain exposure to XENE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold XENE, sorted by portfolio weight.